Moderna has announced a revised supply agreement with the UK government for up to 60 million doses of its Covid-19 vaccine, which may include authorised booster vaccine candidates, with up to 29 million doses expected to be delivered in 2022 and up to 31 million doses expected to be delivered in 2023.
The agreement
Under the agreement, the UK government retains a right to increase its purchases in 2022 and 2023 by up to 20% above the contracted volumes, or to decrease by the same amount.
Official comments
“We thank the UK government for their support in this supply agreement for our mRNA Covid-19 vaccine and booster candidates, if approved, in 2022 and 2023,” said Stéphane Bancel, Moderna’s Chief Executive Officer. “This agreement reflects the efforts of the UK government to address the ongoing pandemic and builds on our existing collaboration to protect people in the UK.”
Image credit: Gerd Altmann
